Skip to main content

View full-text article in PMC

. 2002 Apr 15;8(2):230–232. doi: 10.3748/wjg.v8.i2.230

Table 3.

The influence of Met⁺Hcy^- or Met^-Hcy⁺ in combination with chemotherapeutic drugs to

Drug	Met⁺Hcy^-	Met^-Hcy⁺
ADM	0.3807 ± 0.3114	0.3175 ± 0.2003^a
DDP	0.3878 ± 0.3050	0.3189 ± 0.1848^b
5-FU	0.3657 ± 0.2597	0.3182 ± 0.2049^a
MMC	0.3861 ± 0.2734	0.3105 ± 0.2103^b
MTX	0.3649 ± 0.2811	0.3120 ± 0.2003^b
Control	0.4834 ± 0.4337	0.3981 ± 0.3056^b

gastric cancer cells (¯x ± s, A)

^a

P < 0.05,

^b

P < 0.01, vs Met⁺Hcy^-.